Can bioactive compounds of Crocus sativus L. influence the metabolic activity of selected CYP enzymes in the rat?
Language English Country Czech Republic Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
26681074
DOI
10.33549/physiolres.933203
PII: 933203
Knihovny.cz E-resources
- MeSH
- Enzyme Activation drug effects physiology MeSH
- Crocus * MeSH
- Cyclohexenes isolation & purification pharmacology MeSH
- Microsomes, Liver drug effects enzymology MeSH
- Carotenoids isolation & purification pharmacology MeSH
- Rats MeSH
- Rats, Wistar MeSH
- Plant Extracts isolation & purification pharmacology MeSH
- Cytochrome P-450 Enzyme System metabolism MeSH
- Terpenes isolation & purification pharmacology MeSH
- Dose-Response Relationship, Drug MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- crocin MeSH Browser
- Cyclohexenes MeSH
- Carotenoids MeSH
- Plant Extracts MeSH
- safranal MeSH Browser
- Cytochrome P-450 Enzyme System MeSH
- Terpenes MeSH
Safranal and crocin are biologically active compounds isolated from Crocus sativus L., commonly known as saffron. Clinical trials confirm that saffron has antidepressant effect, thus being a potential valuable alternative in the treatment of depression. The aim of the present study was to determine, whether systemic administration of safranal and crocin can influence the metabolic activity of CYP3A, CYP2C11, CYP2B, and CYP2A in rat liver microsomes (RLM). The experiments were carried out on male Wistar albino rats intragastrically administered with safranal (4, 20, and 100 mg/kg/day) or with intraperitoneal injections of crocin (4, 20, and 100 mg/kg/day). Our results demonstrate the ability of safranal and crocin to increase the total protein content and to change the metabolic activity of several CYP enzymes assessed as CYP specific hydroxylations of testosterone in RLM. Crocin significantly decreased the metabolic activity of all selected CYP enzymes, while safranal significantly increased the metabolic activity of CYP2B, CYP2C11 and CYP3A enzymes. Therefore, both substances could increase the risk of interactions with co-administered substances metabolized by cytochrome P450 enzymes.
References provided by Crossref.org
Lycopene increases metabolic activity of rat liver CYP2B, CYP2D and CYP3A